A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma

Background & Aims: There is no generally accepted adjuvant therapy for hepatocellular carcinoma (HCC) after curative resection. Autologous cytokine-induced killer (CIK) cells therapy has been reported to improve outcomes of patients with HCC, but its role as an adjuvant therapy remains unclear....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Xu, Li, Wang, Jun, Kim, Yuhree, Shuang, Ze-yu, Zhang, Yao-jun, Lao, Xiang-ming, Li, Yong-qiang, Chen, Min-shan, Pawlik, Timothy M., Xia, Jian-chuan, Li, Sheng-ping, Lau, Wan-yee
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4839313/
https://ncbi.nlm.nih.gov/pubmed/27141337
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1083671
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados